Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-17

Clinical Trial Update: Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing GLPG3067 in male subjects with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLPG3067

Snippet

Sponsor: Galapagos NV | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED